Triptan-induced disruption of trigemino-cortical connectivity
Standard
Triptan-induced disruption of trigemino-cortical connectivity. / Kröger, Inga L; May, Arne.
in: NEUROLOGY, Jahrgang 84, Nr. 21, 26.05.2015, S. 2124-31.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Triptan-induced disruption of trigemino-cortical connectivity
AU - Kröger, Inga L
AU - May, Arne
N1 - © 2015 American Academy of Neurology.
PY - 2015/5/26
Y1 - 2015/5/26
N2 - OBJECTIVE: The 5-HT1B/D agonists (triptans) are specific headache medications that have no effect on pain as such. Although they are routinely used in the treatment of acute migraine attacks, the underlying mechanisms of action are still a matter of debate.METHODS: Forty-three healthy participants underwent fMRI while receiving trigemino-nociceptive stimulation and control stimuli in a standardized fMRI paradigm. Using a crossover, double-blind, placebo-controlled design, 21 participants (10 women, mean age 26.9, range 20-37 years) received sumatriptan and 22 participants (11 women, mean age 25.5, range 22-32 years) received acetylsalicylic acid (ASA). Administration of medication and saline was randomized between participants of each group resulting in half of the participants receiving saline and the other half receiving the respective medication during the first fMRI data acquisition.RESULTS: While mean pain intensity ratings did not differ significantly between control and medication nor between medications, we found a significant blood oxygen level-dependent signal increase in the trigeminal nuclei and the thalamus after sumatriptan treatment compared with placebo or ASA. In addition, we specifically looked for the pharmacologic modulation of functional coupling between trigeminal nuclei and higher brain areas, i.e., trigemino-cortical pathways, and found a strong coupling during the saline condition, which was altered by sumatriptan but not after ASA administration.CONCLUSION: These data suggest that a specific functional inhibition of trigemino-cortical projections is one of the reasons that triptans, unlike pain killers, act highly specifically on headache and migraine but not pain as such.
AB - OBJECTIVE: The 5-HT1B/D agonists (triptans) are specific headache medications that have no effect on pain as such. Although they are routinely used in the treatment of acute migraine attacks, the underlying mechanisms of action are still a matter of debate.METHODS: Forty-three healthy participants underwent fMRI while receiving trigemino-nociceptive stimulation and control stimuli in a standardized fMRI paradigm. Using a crossover, double-blind, placebo-controlled design, 21 participants (10 women, mean age 26.9, range 20-37 years) received sumatriptan and 22 participants (11 women, mean age 25.5, range 22-32 years) received acetylsalicylic acid (ASA). Administration of medication and saline was randomized between participants of each group resulting in half of the participants receiving saline and the other half receiving the respective medication during the first fMRI data acquisition.RESULTS: While mean pain intensity ratings did not differ significantly between control and medication nor between medications, we found a significant blood oxygen level-dependent signal increase in the trigeminal nuclei and the thalamus after sumatriptan treatment compared with placebo or ASA. In addition, we specifically looked for the pharmacologic modulation of functional coupling between trigeminal nuclei and higher brain areas, i.e., trigemino-cortical pathways, and found a strong coupling during the saline condition, which was altered by sumatriptan but not after ASA administration.CONCLUSION: These data suggest that a specific functional inhibition of trigemino-cortical projections is one of the reasons that triptans, unlike pain killers, act highly specifically on headache and migraine but not pain as such.
KW - Adult
KW - Anti-Inflammatory Agents, Non-Steroidal
KW - Aspirin
KW - Cerebral Cortex
KW - Double-Blind Method
KW - Female
KW - Humans
KW - Magnetic Resonance Imaging
KW - Male
KW - Neural Pathways
KW - Nociception
KW - Serotonin 5-HT1 Receptor Agonists
KW - Sodium Chloride
KW - Sumatriptan
KW - Thalamus
KW - Trigeminal Nuclei
KW - Young Adult
U2 - 10.1212/WNL.0000000000001610
DO - 10.1212/WNL.0000000000001610
M3 - SCORING: Journal article
C2 - 25948722
VL - 84
SP - 2124
EP - 2131
JO - NEUROLOGY
JF - NEUROLOGY
SN - 0028-3878
IS - 21
ER -